UPMC settles another mold death lawsuit for $1.35M

A second lawsuit stemming from the deadly mold outbreak at Pittsburgh-based UPMC was settled for $1.35 million, according to a Trib Live report.

Advertisement

The family of heart transplant patient Shelby Slagle agreed to the same settlement amount as the family of Tracy Fischer, another heart transplant patient at UPMC. Ms. Slagle and Ms. Fischer were two of four transplant patients at UPMC who died after contracting fungal infections post-transplant.

The mold problem was discovered in September 2015, and in May, a CDC report linked the improper use of negative-pressure rooms as a possible source of the fungal infections.

“The room within UPMC to which the decedent was assigned post-transplant was found to have been infested with Rhizomucor, a type of mold,” the settlement agreement says, according to Trib Live. “An autopsy indicated that the cause of the decedent’s death was bacterial and fungal infections.”

The family of one other now-deceased patient, Che DuVall, has brought a lawsuit against UPMC, but has not been approached for a settlement, according to the report.

More articles on legal and regulatory issues:
Lee Memorial sues Florida Blue over ER payments
Florida nurse arrested on 131 felony charges
12 latest healthcare industry lawsuits, settlements

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Download Whitepaper

The cost-saving opportunity most health systems overlook

Many hospitals and health systems scrutinize staffing, service lines, and payer contracts for savings. Fewer look at one of their largest assets: real estate.…

Advertisement

Next Up in Legal & Regulatory Issues

Advertisement

Comments are closed.